Clinical Trial ID: NCT03651752
Check the eligibility requirements, study details, and more.
The aim of this study is to determine whether topical crisaborole improves hair growth in alopecia areata.
Trial Type
Interventional
Trial Phase
Phase 2
Sponsorship
Pfizer
Alopecia areata is a medical condition, in which the hair falls out in patches. The hair can fall out on the scalp or elsewhere on the face and body. Alopecia areata is an autoimmune skin disease, which means...
Rockefeller University
The purpose of this study is to examine fecal transfer as a potential treatment for Alopecia Areata (AA). This trial will attempt to discover if fecal transfer can treat immune-related hair loss.
Columbia University
